OpenURL Connection Search

Select item for more details and to access through your institution.

DiGeorge Syndrome Diagnosed at Age 38: Challenges in Low-resource Settings and Implications of a Missed Diagnosis.
Published in:
JCEM Case Reports, 2024, v. 2, n. 7, p. 1, doi. 10.1210/jcemcr/luae136
By:
- Kuenstner, William;
- Rapisuwon, Suthee;
- Shobab, Leila
Publication type:
Article
Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma.
Published in:
JAMA Network Open, 2023, v. 6, n. 8, p. e2327145, doi. 10.1001/jamanetworkopen.2023.27145
By:
- Goodman, Rachel S.;
- Lawless, Aleigha;
- Woodford, Rachel;
- Fa'ak, Faisal;
- Tipirneni, Asha;
- Patrinely, J. Randall;
- Yeoh, Hui Ling;
- Rapisuwon, Suthee;
- Haydon, Andrew;
- Osman, Iman;
- Mehnert, Janice M.;
- Long, Georgina V.;
- Sullivan, Ryan J.;
- Carlino, Matteo S.;
- Menzies, Alexander M.;
- Johnson, Douglas B.
Publication type:
Article
The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
Published in:
2016
By:
- Shoushtari, Alexander N.;
- Munhoz, Rodrigo R.;
- Kuk, Deborah;
- Ott, Patrick A.;
- Johnson, Douglas B.;
- Tsai, Katy K.;
- Rapisuwon, Suthee;
- Eroglu, Zeynep;
- Sullivan, Ryan J.;
- Luke, Jason J.;
- Gangadhar, Tara C.;
- Salama, April K. S.;
- Clark, Varina;
- Burias, Clare;
- Puzanov, Igor;
- Atkins, Michael B.;
- Algazi, Alain P.;
- Ribas, Antoni;
- Wolchok, Jedd D.;
- Postow, Michael A.
Publication type:
journal article
A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis.
Published in:
Oncologist, 2021, v. 26, n. 3, p. e505, doi. 10.1002/onco.13608
By:
- Randall Patrinely, J.;
- Funck‐Brentano, Elisa;
- Nguyen, Khang;
- Rapisuwon, Suthee;
- Salem, Joe‐Elie;
- Gibney, Geoffrey T.;
- Carlino, Matteo;
- Johnson, Douglas B.
Publication type:
Article
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
Published in:
Cancer (0008543X), 2024, v. 130, n. 9, p. 1642, doi. 10.1002/cncr.35179
By:
- Miller, Eric J.;
- Rose, Tracy L.;
- Maughan, Benjamin L.;
- Milowsky, Matthew I.;
- Bilen, Mehmet A.;
- Carthon, Bradley C.;
- Gao, Xin;
- Rapisuwon, Suthee;
- Zhao, Qianqian;
- Yu, Menggang;
- Agarwal, Neeraj;
- Galsky, Matthew D.
Publication type:
Article

Found: 5

DiGeorge Syndrome Diagnosed at Age 38: Challenges in Low-resource Settings and Implications of a Missed Diagnosis.

Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma.

The efficacy of anti-PD-1 agents in acral and mucosal melanoma.

A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis.

Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.